Drug Type Monoclonal antibody |
Synonyms |
Target |
Mechanism CLEC14A inhibitors(C-type lectin domain containing 14A inhibitors) |
Therapeutic Areas |
Active Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Phase 3 | KR | - | |
Dystrophy, Macular | Preclinical | KR | - |